Here, using patient tissue samples, cell culture studies, and animal cancer models we show that ST6GAL1 is upregulated in men with prostate cancer bone metastasis, and reveal aberrant sialylation can promote the spread of prostate cancer to bone. Here, ST6GAL1 is linked to prostate carcinoma.